Company intelligence / Profile preview

Advanced Chemical Industries

Dhaka, Dhaka, Bangladesh

Ownership: Private
Employees: ~11267
Development stage: Other

Overview

ACI consistently launches new pharmaceutical molecules (>30 new in 2018–19), markets >250 pharma molecules, covers ~100 therapeutic classes, exports to 30 countries, and is continuously expanding biosimilar and novel drug delivery products.

Therapeutic areas: EndocrinologyMetabolic DisordersOphthalmologyInfectious DiseasesPulmonologyCardiovascularOtherOncology
Modalities: Small moleculeBiologicBiosimilarHormoneRecombinant proteinNovel drug delivery systemLarge volume parenteralSmall volume parenteral
Industry: Biotech

Partnerships

AstraZeneca (marketing Arimidex, Casodex, Zoladex in Bangladesh)UCB Belgium (Atarax)Servier (contract manufacturing)Tetley (joint venture)Godrej Agrovet (joint venture)Asian Consumer Care (joint venture)

Beyond the preview

Go deeper on Advanced Chemical Industries.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Advanced Chemical Industries.

Explore the full profile